Literature DB >> 6222114

The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen.

P E Lipsky, P A Thompson, L J Rosenwasser, C A Dinarello.   

Abstract

The role of factors released by monocytes (M phi) in the activation of human B lymphocytes was examined by studying the effect of an antiserum against human leukocytic pyrogen (LP) on mitogen-stimulated B cell proliferation and the generation of immunoglobulin-secreting cells (ISC) by peripheral blood mononuclear cells (PBM). Antiserum against LP was obtained from rabbits immunized with LP-containing human M phi supernatants. The globulin fraction of this antiserum inhibited pokeweed mitogen- (PWM) stimulated B cell proliferation and the generation of ISC in a concentration-dependent manner, with 50% inhibition of responsiveness observed with 10 micrograms/ml. By contrast, PWM-induced T cell [3H]thymidine incorporation was not inhibited by concentrations of anti-LP as great as 2000 micrograms/ml. The F(ab')2 fraction of anti-LP also inhibited the generation of ISC in response to both PWM and formalinized Staphylococcus aureus, but required 50 micrograms/ml to achieve 50% inhibition. Anti-LP inhibited the generation of ISC only if present during the first 24 hr of a 6 to 7-day incubation; later addition was not inhibitory. Inhibition was more marked in cultures partially depleted of M phi than in whole PBM cultures. Whereas absorption of the anti-LP with PBM failed to remove the capacity to inhibit the generation of ISC, anti-LP-mediated inhibition of responsiveness could be reversed by the addition of crude M phi culture supernatants or a variety of highly purified interleukin 1 (IL 1) preparations, but not by T cell supernatants. These results indicate anti-LP inhibits human B cell activation by removing the requisite M phi-derived factor IL 1 and also confirm that IL 1 plays an essential role in B cell proliferation and the generation of ISC in man.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6222114

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  An analysis of the growth and differentiation of B cells isolated from follicles of the ileal Peyer's patch of sheep.

Authors:  P J Griebel; W C Davis; J D Reynolds
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

Review 3.  DNA gene vaccination for HIV.

Authors:  J J Kim; D B Weiner
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Immunomodulating activity in supernatants from EBV immortalized lymphocytes.

Authors:  B A Blazar; L M Sutton; M Strome
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19.

Authors:  J A Ledbetter; P S Rabinovitch; C H June; C W Song; E A Clark; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Immunoregulating activity of tumor-associated macrophages.

Authors:  G J Dougherty; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Expression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies.

Authors:  S M Hsu; X Zhao
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

8.  Immunodeficiency with defective T-cell response to interleukin 1.

Authors:  E T Chu; L J Rosenwasser; C A Dinarello; F S Rosen; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Demonstration of interleukin 1 activity in apparently homogeneous specimens of the pI 5 form of rabbit endogenous pyrogen.

Authors:  D F Hanson; P A Murphy
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Enhanced resistance of mice to bacterial infection induced by recombinant human interleukin-1a.

Authors:  Y Ozaki; T Ohashi; A Minami; S Nakamura
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.